Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression
暂无分享，去创建一个
I. Soubeyran | C. Sautès-Fridman | M. Toulmonde | A. Italiano | W. Fridman | J. Soria | C. Rey | B. Besse | Y. Loriot | C. Bellera | M. Kind | F. Le Loarer | V. Vélasco | A. Marabelle | A. Savina | S. Pernot | S. Le Moulec | G. Roubaud | J. Guégan | S. Cousin | A. Bessede | C. Sofeu | M. Cabart | F. Chomy | Mathieu Larroquette | M. Brunet | K. Bourcier | Félicie Courgeon | Ilenia Giglioli | L. Vanhersecke | A. Bougouin | C. Lefevre | Ezoglin Oflazoglu | F. Le Loarer | Mathieu Larroquette